Advancing pharmacometrics in Africa – Transition from capacity development toward job creation Blog Post
This CPT article showcases, the Applied Pharmacometrics Training (APT) program, launched in 2021 by Pharmacometrics Africa with support from the Bill & Melinda Gates Foundation, Certara, and others, addresses the...
Sneak Preview: Introducing TFL Studio Blog Post
Get your preview of the upcoming Tables, Figures, and Listings (TFL) Module in Phoenix Cloud. Learn how this innovative tool will revolutionize the way you create and manage TFLs, providing faster results, enhanced flexibility, and streamlined collaboration.
Key development considerations for cell therapies Blog Post
Rajesh Krishna, PhD Kathryn Brown December 5, 2024 What is a “cell therapy”? Nearly every recent oncology clinical conference has featured this phrase. Cell therapies, such as CAR-Ts (chimeric antigen...
Quantitative Systems Pharmacology-Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease Blog Post
Publication: Clinical Pharmacology & Therapeutics: Volume 117, Issue 2 Abstract Pompe disease is a rare, progressive neuromuscular disease caused by deficient lysosomal glycogen degradation, and includes both late-onset (LOPD) and...
GlobalSubmit 4.0 Webinars Blog Post
The world of electronic regulatory submissions is about to change with the introduction of eCTD (Electronic Common Technical Document) v4.0. This latest version of the standard includes updated specifications and guidelines for the preparation and submission of electronic regulatory documents.
CDISC SEND V3.1.1 Updates Nonclinical Drug Developers Need to Know Blog Post
Peggy Zorn December 3, 2024 The Standard for Exchange of Nonclinical Data (SEND) is a standardized, electronic format for exchanging nonclinical drug development data. SEND was developed by the Clinical Data Interchange Standards...
Certara Showcases 2024 Research Wins with Over 100 Papers Published Blog Post
The company celebrates the 12 scientists included in the Stanford/Elsevier top 2% cited researchers list RADNOR, PA – December 2, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in…
